RNAM
Avidity Biosciences Inc
2월 26일 4:00 PM ET (한국 2/27 06:00)
$72.82
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -4.96 | Insider Own | 5.98% | Shs Outstand | 0.15B | Perf Week | - |
| Market Cap | 11.30B | Forward P/E | - | EPS next Y | -16.28% | Insider Trans | - | Shs Float | 0.15B | Perf Month | -0.14% |
| Enterprise Value | 9.65B | PEG | - | EPS next Q | -1.36 | Inst Own | 92.11% | Short Float | 6.18% | Perf Quarter | 2.06% |
| Income | -0.68B | P/S | 602.56 | EPS this Y | -54.81% | Inst Trans | - | Short Ratio | 3.34 | Perf Half Y | 77.44% |
| Sales | 0.02B | P/B | 6.52 | EPS next 5Y | -10.16% | ROA | -38.88% | Short Interest | 9.01M | Perf YTD | 0.96% |
| Book/sh | 11.17 | P/C | 6.66 | EPS past 3/5Y | -14.23% -19.41% | ROE | -43.98% | 52W High | -0.33% ($73.06) | Perf Year | 145.6% |
| Cash/sh | 10.94 | P/FCF | - | Sales past 3/5Y | 26.69% 22.54% | ROIC | -39.48% | 52W Low | 238.54% ($21.51) | Perf 3Y | 219.81% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -71.19% | Gross Margin | 77.87% | Volatility(W/M) | 0.33% 0.31% | Perf 5Y | 201.78% |
| Dividend TTM | - | EV/Sales | 514.69 | Sales Y/Y TTM | 72.11% | Oper. Margin | -3977.3% | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.2 | EPS Q/Q | -99.6% | Profit Margin | -3650.39% | RSI (14) | 58.41 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.2 | Sales Q/Q | -71.07% | SMA20 | 0% ($72.82) | Beta | 0.98 | Target Price | $72.67 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 11000000 | SMA50 | 0.42% ($72.52) | Rel Volume | 0 | Prev Close | $72.82 |
| Employees | 511 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | -17.02% 545.33% | SMA200 | 38.23% ($52.68) | Avg Volume(3M) | 2.70M | Price | $72.82 |
| IPO | 2020/6/12 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
뉴스 로딩 중...